JAZZ vs TEL · P/E 1988, rev $4.07B vs P/E 39, rev $17.26B
Jazz Pharmaceuticals PLC (JAZZ) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. Revenue was up 8.9% from 2024-09-27 to 2025-09-26. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the JAZZ and TEL stock pages for the full models.
Not investment advice.